Genes & Diseases

Scope & Guideline

Connecting genetics to disease for transformative insights.

Introduction

Immerse yourself in the scholarly insights of Genes & Diseases with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2352-4820
PublisherKEAI PUBLISHING LTD
Support Open AccessYes
CountryChina
TypeJournal
Convergefrom 2014 to 2024
AbbreviationGENES DIS / Genes Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG DISTRICT 100009, PEOPLES R CHINA

Aims and Scopes

The journal 'Genes & Diseases' focuses on the intersection of genetics and various diseases, emphasizing the molecular mechanisms underlying disease pathology and potential therapeutic interventions. It provides a platform for innovative research that integrates genomics, molecular biology, and clinical applications.
  1. Molecular Genetics and Disease Mechanisms:
    Research exploring the genetic basis of diseases, including the identification of mutations, polymorphisms, and their roles in disease progression.
  2. Transcriptional and Epigenetic Regulation:
    Studies on how transcriptional control and epigenetic modifications influence gene expression in the context of various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular mechanisms of cancer, including tumor microenvironment interactions, signaling pathways, and therapeutic targets.
  4. Immunology and Autoimmunity:
    Research on immune responses in disease states, including the role of immune checkpoints, inflammatory pathways, and autoimmune conditions.
  5. Stem Cell Biology and Regenerative Medicine:
    Exploration of stem cell mechanisms, differentiation, and their therapeutic applications in disease treatment and tissue regeneration.
  6. Metabolism and Disease:
    Studies on metabolic pathways and their alterations in diseases such as obesity, diabetes, and cancer, focusing on therapeutic implications.
  7. Neurobiology and Neurodegenerative Diseases:
    Research into the genetic and molecular underpinnings of neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
  8. Infectious Diseases and Host Response:
    Investigations into the genetic factors affecting susceptibility to infectious diseases and the host's immune response mechanisms.
The journal 'Genes & Diseases' has been at the forefront of exploring new and innovative research themes. Recent publications indicate a significant shift towards several trending and emerging scopes that reflect the current landscape of biomedical research.
  1. Multi-Omics Approaches:
    There is a growing emphasis on integrating genomic, transcriptomic, proteomic, and metabolomic data to provide a comprehensive understanding of disease mechanisms and therapeutic targets.
  2. Precision Medicine and Personalized Therapies:
    Research focused on tailoring treatment strategies based on genetic and molecular profiling of patients is gaining traction, reflecting the shift towards individualized healthcare.
  3. Ferroptosis and Regulated Cell Death:
    Ferroptosis, a form of regulated cell death, is emerging as a significant area of research, particularly in its implications for cancer therapy and neurodegenerative diseases.
  4. Immunotherapy and Cancer Microenvironment:
    Studies exploring the interactions between cancer cells and the immune microenvironment, including the role of immune checkpoints and tumor-infiltrating lymphocytes, are increasingly prominent.
  5. Gene Editing Technologies:
    The application and implications of CRISPR and other gene editing technologies in treating genetic disorders and cancers are trending, highlighting their potential for future therapies.
  6. Role of Non-Coding RNAs in Disease:
    Research into the functions and mechanisms of long non-coding RNAs (lncRNAs) and circular RNAs in various diseases is on the rise, emphasizing their potential as biomarkers and therapeutic targets.
  7. Microbiome and Human Health:
    Explorations of the relationship between the microbiome and various diseases, including metabolic and autoimmune conditions, are becoming a significant focus.
  8. Neuroinflammation and Neurodegeneration:
    Research on the mechanisms of neuroinflammation and its role in neurodegenerative diseases is gaining importance, reflecting a broader understanding of brain health.

Declining or Waning

While 'Genes & Diseases' continues to expand its focus on various emerging themes, certain areas appear to be experiencing a decline in prominence. These waning scopes may reflect shifts in research priorities or advancements in scientific understanding.
  1. Traditional Genetic Association Studies:
    While genetic association studies remain important, there has been a noticeable shift toward more integrative approaches that combine genomics with other omics data, leading to a decline in standalone genetic association studies.
  2. Basic Mechanistic Studies Without Clinical Relevance:
    Research that focuses solely on basic mechanisms without a clear clinical application or relevance is becoming less frequent, as the journal prioritizes studies with translational potential.
  3. Single-Factor Analyses in Complex Diseases:
    There is a decrease in studies that analyze single genetic or molecular factors in complex diseases, with a growing preference for multi-factorial and systems biology approaches.
  4. Historical Reviews on Established Diseases:
    Reviews focusing on well-established diseases without new insights or perspectives are waning, as the journal seeks fresh, innovative content that addresses current research gaps.

Similar Journals

FASEB BioAdvances

Driving Innovation in Molecular Biology Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Life Science Alliance

Advancing the Frontiers of Life Sciences.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

CELLULAR AND MOLECULAR BIOLOGY

Exploring the Intricacies of Cellular Mechanisms
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

BMC Molecular and Cell Biology

Empowering open access to vital biological research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Frontiers in Bioscience-Landmark

Elevating Knowledge in Biochemistry and Beyond
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Connecting Molecular Insights to Clinical Applications
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

MOLECULAR MEDICINE

Bridging Research and Practice in Molecular Medicine
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

BMB Reports

Advancing the Frontiers of Biochemistry and Molecular Biology
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

FEBS Journal

Advancing the Frontiers of Biochemical Research
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

Cell Reports

Catalyzing Scientific Breakthroughs Across Disciplines
Publisher: CELL PRESSISSN: 2211-1247Frequency: 48 issues/year

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.